Maxim Group dropped their price target on shares of Fluidigm (NASDAQ:FLDM) from $65.00 to $52.00 in a research note issued on Tuesday, AR Network reports. The firm currently has a “buy” rating on the stock. Maxim Group’s target price would indicate a potential upside of 58.97% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Leerink Swann cut their price target on shares of Fluidigm from $52.00 to $48.00 in a research note on Tuesday. Separately, analysts at Mizuho upgraded shares of Fluidigm from a “neutral” rating to a “buy” rating in a research note on Tuesday, April 22nd. They now have a $50.00 price target on the stock, up previously from $43.00. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $44.76.
Fluidigm (NASDAQ:FLDM) opened at 32.08 on Tuesday. Fluidigm has a 1-year low of $15.72 and a 1-year high of $49.46. The stock has a 50-day moving average of $39.17 and a 200-day moving average of $38.13. The company’s market cap is $862.9 million.
Fluidigm (NASDAQ:FLDM) last issued its quarterly earnings data on Monday, May 5th. The company reported ($0.57) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.31) by $0.26. The company had revenue of $25.70 million for the quarter, compared to the consensus estimate of $22.91 million. The company’s quarterly revenue was up 77.2% on a year-over-year basis. Analysts expect that Fluidigm will post $-1.89 EPS for the current fiscal year.
Fluidigm Corporation (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.